US EPA moves to approve dicamba weedkiller use on cotton, soybeans

The U.S. Environmental Protection Agency (EPA) has proposed re-approving three dicamba weedkiller products, previously halted by a 2024 federal court ruling over procedural violations, citing no significant human health risk while proposing application restrictions to mitigate plant damage. This move, following applications from companies like Bayer and BASF, could reintroduce a critical agricultural tool for cotton and soybean farmers, impacting the supply chain for genetically engineered crops and the involved chemical manufacturers.

Analysis

The U.S. Environmental Protection Agency (EPA) has proposed the re-approval of three dicamba-based weedkiller products from manufacturers including Bayer (BAYRY) and BASF (BASFn), a notable development following a 2024 federal court order that vacated their registrations and halted usage. The agency's assessment concluded there is no significant human health risk, but it acknowledges risks to non-target plants, which it aims to mitigate through new restrictions on application quantity and timing. This regulatory shift is a direct potential benefit for Bayer and BASF, which could see the resumption of sales for key products like Bayer's XtendiMax, a critical tool for genetically engineered cotton and soybean crops. However, the proposal faces headwinds from environmental groups concerned about the chemical's drift and potential for crop damage. Furthermore, the disclosure that a key EPA official previously lobbied for the pro-dicamba American Soybean Association could fuel legal challenges and public scrutiny, representing a non-trivial risk to the final approval. The article's headline mentioning Alphabet is erroneous and disconnected from the body of the text, which focuses exclusively on the agrochemical sector.

Key Decisions for Investors

• The EPA's proposed re-approval of dicamba is a significant positive catalyst for Bayer and BASF; investors should monitor the final regulatory decision as it could restore a key revenue stream previously halted by court order.
• Key risks to monitor include potential legal challenges from environmental groups and scrutiny over the regulatory process itself, which could introduce volatility or delays to the re-approval timeline.
• Investment decisions regarding Alphabet (GOOG, GOOGL) should not be influenced by this article, as its headline is irrelevant to the actual content provided.